Canada SynBio 2019 – Pitch Competition

December 7, 2018

Accelerating Start-ups by Design
Canada SynBio 2019
Pitch Competition Program Overview

Are you a Canadian-based startup company working to commercialize a synbio-based product or service? We want you to apply to pitch for up to $25,000 in prize money in front of leading investors!


Startup companies will be competing for a first prize of $25,000 and second prize of $10,000


  • Startups must be based in Canada and have raised less than $3M in financing
  • Products or services being developed by the company must be based on an engineered biological (synbio) technology
  • Companies must demonstrate access to lab resources required
  • Individuals and students are welcome to apply, but must incorporate as a company if successful in order to receive funds

Program Overview

Application FormStage 1- Submission of written application (January 16th deadline)

  • Startups are invited to submit a written proposal to Ontario Genomics via the application form. Questions cover:
    • The problem you are trying to solve
    • Description of your product or service and differentiation
    • How you are engineering biology and your team’s experience working on this technology
    • Your business plan and estimated timeline to market
    • How the funding will be used

Stage 2- Interview (early February)

  • The top companies based on a pre-screen will be selected for an interview conducted over video conferencing (details on format to be provided to companies selected)
  • The top 6 companies selected from the interview will be invited to pitch in person at the Canada SynBio 2019 conference on March 6th

Stage 3- Mandatory Practice Pitches (mid-February)

  • Teams must present their pitches over video conferencing for feedback

March 6th- Pitch Competition

  • Each company will be given 7 minutes to pitch to a panel of judges consisting of investors who will select the top two companies for awards


  • The funding is offered as a grant, without any ownership stake in the company or any intellectual property being taken by Ontario Genomics or its partners
  • Periodic reporting on the impact of the funding received will be required

For questions please contact Britney Hess, Manager, Investment and Venture Development

Back to 2019 Canada SynBio page